Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

After all the reverse splits and falling prices

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BesaoT35 Member Profile
Member Level 
Followed By 2
Posts 455
Boards Moderated 0
Alias Born 07/08/13
160x600 placeholder
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/7/2020 6:01:32 AM
InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference Business Wire - 9/11/2020 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/11/2020 4:15:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 4:34:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 6:37:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/22/2020 6:04:21 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/9/2020 4:31:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/5/2020 4:06:18 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/5/2020 6:01:40 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 6/4/2020 4:35:19 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 5/22/2020 5:26:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2020 4:07:21 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/28/2020 4:15:49 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/24/2020 5:05:10 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/24/2020 4:15:10 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/24/2020 11:19:24 AM
InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Business Wire - 4/17/2020 12:19:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/17/2020 6:01:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2020 5:20:33 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/16/2020 11:30:13 AM
InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Business Wire - 4/15/2020 7:30:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/16/2020 4:45:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/12/2020 7:02:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/12/2020 7:02:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/12/2020 7:02:11 PM
BesaoT35 Member Level  Friday, 05/01/20 11:24:20 AM
Re: None
Post # of 6164 
After all the reverse splits and falling prices the market cap for NVIV is very low. It is below $10 million. If the neuro - spinal scaffold (NSS) is a success it has to be worth more than that I think. The first trial was a success. That makes me think the Inspire 2 could be successful. This is all before even using stem cells or growth factors.

After all this time NVIV might have competitors whereas a few years ago there were no direct competitors.

What do people think NVIV would be worth after approval for use of the NSS and then use of stem cells?

I do know that management is corrupt and perhaps incompetent as well. I think our previous CEO Dr. Reynolds actually is in jail or soon to be sentenced to go to jail. That is real undeniable corruption.

This is all a shame. I think about helping patients and how all the delay has hampered finding treatment.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences